Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Nextcure Inc (NXTC)

9.12   -0.19 (-2.04%) 08-14 16:00
Open: 9.34 Pre. Close: 9.31
High: 9.34 Low: 8.94
Volume: 723,600 Market Cap: 251M
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase 2 clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, is a novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules that targets a novel member of the B7-family of immunomodulatory proteins; and an antibody in preclinical development targeting an immune modulator that is expressed in inflamed tissue and the tumor microenvironment in various tumor types. NextCure, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.351 - 9.41 9.41 - 9.451
Low: 8.804 - 8.875 8.875 - 8.926
Close: 9.025 - 9.131 9.131 - 9.206

Technical analysis

as of: 2020-08-14 4:32:52 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 12.93     One year: 15.15
Support: Support1: 8.00    Support2: 6.66
Resistance: Resistance1: 11.07    Resistance2: 12.97
Pivot: 9.34
Moving Average: MA(5): 9.47     MA(20): 9.38
MA(100): 25.49     MA(250): 35.30
MACD: MACD(12,26): -1.83     Signal(9): -2.40
Stochastic oscillator: %K(14,3): 40.93     %D(3): 46.62
RSI: RSI(14): 29.14
52-week: High: 109.00  Low: 8.00  Change(%): -66.0
Average Vol(K): 3-Month: 87144  10-Days: 80748

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NXTC has closed above bottom band by 32.3%. Bollinger Bands are 85.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to NXTC's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 14 Aug 2020
Perhaps NextCure, Inc. (NXTC) Has Found Some Support In The Market Place - Invest Million

Thu, 06 Aug 2020
NextCure Reports Second Quarter 2020 Financial Results Nasdaq:NXTC - GlobeNewswire

Wed, 05 Aug 2020
NextCure to Present at BTIG Virtual Biotechnology Conference - GlobeNewswire

Tue, 04 Aug 2020
How Will the Market React to NextCure Inc (NXTC) Stock Getting a Bullish Rating - InvestorsObserver

Mon, 03 Aug 2020
Will NextCure, Inc. (NXTC) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance

Fri, 31 Jul 2020
NextCure, Inc. (NXTC) set up for great things - The News Heater

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 28
Shares Float (M) 15
% Held by Insiders 13.53
% Held by Institutions 82.34
Shares Short (K) 2,120
Shares Short P. Month (K) 1,230

Stock Financials

EPS -0.810
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 12.060
Profit Margin -65.22
Operating Margin -82.05
Return on Assets (ttm) -5.7
Return on Equity (ttm) -8.1
Qtrly Rev. Growth 1549.1
Gross Profit (p.s.) -1.013
Sales Per Share 0.995
EBITDA (p.s.) -0.711
Qtrly Earnings Growth
Operating Cash Flow (M) -39
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -11.26
PEG Ratio
Price to Book value 0.76
Price to Sales 9.17
Price to Cash Flow -6.41

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.